Skip to main content

Therapeutics Startups

Updated July 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,708 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,708
Total Funding
$1.3B
Avg Funding
$51.8M
Global Reach
8
countries

Top Cities for Therapeutics

Seattle
Germantown
Sydney
Washington
Nagoya
Melbourne

Recently Funded Companies

Export
Seattle, United States

Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.

$52.8M raised
Nov 2022

Founder Contacts

30,000+ verified contacts

Germantown, United States

Morgenesis is a subsidiary of Orgenesis, and it provides point-of-care services.

$30.0M raised
Nov 2022

Founder Contacts

30,000+ verified contacts

Sydney, Australia

Understanding Zoe is a neuroaffirming application that turns every report and observation into an actionable step for a better connect.

$499K raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Washington, United States

Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.

$9.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Nagoya, Japan

Crafton Biotechnology is a biotechnology company that researches, develops, and sells pharmaceutical products.

$679K raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Melbourne, Australia

Prota Therapeutics is a developer of new treatment for peanut allergy in children.

$21.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Multus is a global leader in cell culture media design for cell-based biomanufacturing, combining AI, robotic automation, and cell biology.

$9.5M raised
Jan 2023

Founder Contacts

30,000+ verified contacts

Surrey, Canada

Eyam Health concentrates on the investigation and creation of vaccines for defending against infectious diseases.

$327K raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Salt Lake City, United States

CaLycia Bioscience is a biotechnology startup that develops myeloid-based cell therapy for treating tumors such as glioblastoma.

$400K raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Dortmund, Germany

Qli5 Therapeutics develops a new class of proteasome inhibitors.

$7.2M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Halifax, Canada

Appili Therapeutics is an anti-infective pharmaceutical development company.

$532K raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Redwood City, United States

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

$350.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

$185.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Houston, United States

At Speratum, we're developing a robust RNAi platform targeting key oncogenic drivers in solid tumors.

$581K raised
Nov 2024

Founder Contacts

30,000+ verified contacts

O'fallon, United States

Holos Wellness offers tech-based healthcare services including corrective exercises, integrated nutrition, and PNF stretching.

$317K raised
Nov 2024

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Cognomie provides access to coaching, counseling, and therapy to help organizations develop skills, insight, belief, and fulfillment.

$489K raised
Nov 2021

Founder Contacts

30,000+ verified contacts

Garden City, United States

Beyond Air is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.

$5.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Los Angeles, United States

MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.

$400K raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Berkeley, United States

Vivere develops targeted cancer therapies that activate the immune system to detect and destroy tumors using engineered bio-platforms.

$10.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Copenhagen, Denmark

BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.

$3.6M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Sonoma Biotherapeutics develops engineered regulatory T-cell (Treg) therapies to treat autoimmune and inflammatory diseases.

$300K raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Milano, Italy

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

$141.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Raleigh, United States

Caidya is a clinical research organization that provides personalized solutions for various therapeutic areas.

$165.0M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Mountain View, United States

Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.

$32.5M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Chicago, United States

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

$270.0M raised
Nov 2022

Founder Contacts

30,000+ verified contacts

Showing 1451 to 1475 of 1,708 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,708 therapeutics companies tracked in the VCBacked database.

Average Funding
$51.8M
Total Funding Tracked
$1.3B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.London
2 companies$10.0M
2.Seattle
1 companies$52.8M
3.Germantown
1 companies$30.0M
4.Sydney
1 companies$499K
5.Washington
1 companies$9.0M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked